peptide degradation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-04-13 and is reviewed periodically as new material appears.
Published research has focused mainly on neurological and cognitive endpoints in animal models, with proposed mechanisms involving brain-derived neurotrophic factor and related signalling pathways. A substantial share of the human data originates from a limited number of research groups, and independent replication in other countries remains sparse. Regulatory status reflects that distribution: the peptide is registered as a medicine in Russia and appears in some neighbouring markets, while elsewhere it is handled as a research chemical without approved therapeutic labelling. Questions about dose-response relationships, long-term effects, and comparability across studies are still open.
Lyophilised powder is normally kept at -20 °C in a desiccated container, with some suppliers recommending -80 °C for long-term archival storage. Repeated freeze-thaw cycles are the most common cause of avoidable loss, so aliquoting before freezing reduces variability between working sessions. Dissolved peptide is far less stable than the dry solid and is usually prepared fresh or held briefly at 4 °C. Aqueous solutions support both hydrolysis of the backbone and oxidation of the N-terminal methionine, and these two routes dominate degradation under ordinary laboratory conditions.
Verification of a supplied batch generally combines a certificate of analysis with independent testing, because certificates are self-reported documents. A typical package includes a chromatographic trace, a mass spectrum, and a stated water or counter-ion content. Batch-to-batch consistency matters more than a single purity figure when results are compared across experiments. No single mandatory standard governs research-grade peptide release, so laboratories are expected to define their own acceptance criteria. Residual trifluoroacetate from purification is a frequently overlooked counter-ion.
Lyophilized material is chemically stable for extended periods when kept dry, cold, and protected from light. The powder is hygroscopic, so vials should be warmed to room temperature before opening to reduce condensation on the contents. Once dissolved, the peptide is far less stable because peptide bonds are susceptible to hydrolysis and the methionine residue can oxidize. Solutions are typically aliquoted and held at 2-8 °C for short intervals or frozen for longer ones, and repeated freeze-thaw cycles should be avoided.
| Property | Value | Notes |
|---|---|---|
| Purity assay | RP-HPLC, UV 214 nm | Typical research grade 95 percent or higher |
| Mass confirmation | ESI-MS or MALDI-TOF | Compared with theoretical value |
| Main degradation route | Methionine oxidation | Sulfoxide formation in solution |
| Powder storage | -20 °C, desiccated | Amber vial, minimal headspace |
| Working solution | Sterile water or saline | Prepare fresh; avoid repeated thawing |
Pharmacokinetic accounts emphasize rapid breakdown. After intravenous dosing the intact peptide disappears from blood within minutes, and nasal delivery produces low but measurable concentrations. Metabolites rather than the parent molecule may account for part of the observed activity, although the relative contribution is unresolved. Dosing in the literature varies widely and no optimal schedule has been agreed. These gaps are regularly cited as a reason the findings have not produced broad clinical adoption beyond the original research setting.
Proposed mechanisms center on neurotrophic signaling rather than on classical melanocortin receptor activation. Rodent experiments have reported shifts in the expression of brain-derived neurotrophic factor and nerve growth factor after administration, together with changes in the associated receptor systems. Several authors argue that the peptide acts largely through its degradation products and their interaction with peptidergic pathways, but this remains a hypothesis rather than a settled finding. No single molecular target has been identified in a way that the field broadly accepts.
Published research covers ischemic stroke, traumatic brain injury, cognitive impairment, optic nerve conditions and attention-related measures. Much of the human evidence comes from small trials conducted in one country, which limits how far the results generalize. Animal models supply the larger share of the data, and effects seen in rodents do not transfer automatically to people. Reviews have noted that methodological reporting is often incomplete, making it difficult to pool results or compare treatment schedules across studies.
Semax is supplied as a lyophilized powder that appears white to off-white. It dissolves readily in water, phosphate-buffered saline, and other aqueous media, which simplifies preparation of working solutions for laboratory use. The nasal products registered in Russia are dilute aqueous solutions, typically around 0.1 percent peptide by weight. Organic solvents are rarely necessary and can complicate handling. Because the peptide is hygroscopic, weighing should be performed quickly and with minimal exposure to ambient humidity.
Solid material is normally kept at minus 20 degrees Celsius in a sealed, desiccated container. Reconstituted solutions are less stable and are usually divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of activity. Light exposure is minimized by using amber glassware or foil wrapping. Published stability data for this peptide are sparse, so recommended storage conditions rest mainly on general practice for short synthetic peptides rather than on dedicated study.
Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, with ultraviolet detection near 214 nanometers for the peptide backbone. Mass spectrometry, either electrospray or matrix-assisted laser desorption, confirms molecular mass and detects truncation or modification products. Amino acid analysis can verify composition. Because the sequence contains no strongly absorbing aromatic residue apart from phenylalanine, detection wavelengths are chosen carefully. Purity values above 95 percent are typical for research-grade material.
Bomb defusal: The Terrorist team has a bomb when the round starts. The goal of the Terrorists is to plant the bomb at a bomb site—maps generally have two called Bombsite A and Bombsite B—and ensure the bomb goes off after a short timer. The Counter-Terrorist team wins if they are able to defuse the bomb within a set time limit or if the time runs out before the bomb is planted. The Terrorist team wins if the bomb successfully detonates. If either team is eliminated before the bomb is planted or the rounds ends, the other team wins. Bomb defusal maps start with the prefix "de_" (e.g de_dust2). Hostage rescue: Hostages (non-player characters) are located on the map, generally close to the Terrorist spawn point. The goal of the Counter-Terrorist team is to collect hostages and run to a location on the map where they are rescued. Either team may also win if every member of the opposing team is eliminated. The Terrorists win if the round ends due to timing out. Maps with this objective start with the prefix "cs_" (e.g cs_office). Assassination: In this game mode, one Counter-Terrorist member becomes a VIP, armed with a Counter-Terrorist standard-issue USP handgun. The VIP is not permitted to retrieve dropped firearms except their own handgun. Either all the Terrorists die or the VIP must enter an extraction zone within a time limit for the Counter-Terrorists to win. The Terrorists win if the VIP dies or the time limit runs out. Maps with this objective start with the prefix "as_".
The endocrine function of gonadotrophs is derived from the effect of gonadotropins on the reproductive system. The gonadotropins produced by gonadotropic cells are FSH and LH, which are dimeric pituitary glycoprotein hormones with a common alpha subunit and distinct beta subunit that confers biological activity of the hormones. These hormones are synthesized in the ER of gonadotropic cells and then passed through the Golgi apparatus. After modification and packaging within the Golgi complex, the hormones are delivered to the plasma membrane through constitutive or regulated secretory pathways. The regulated pathway involves the fusion of the secretory vesicles containing FSH and LH to the gonadotroph membrane, and the vesicle is arrested waiting for specific signals, such as increased calcium levels from electrical activity and signaling pathways, that activate secretion of the hormones. The gonadotropins FSH and LH regulate the development of follicles, also known as folliculogenesis, in females, and the development of sperm in males. More specifically, the released FSH acts on ovarian granulosa and testicular Sertoli cells, while LH acts on ovarian theca and testicular Leydig cells. The release of these hormones are directly signaled by the pulsing secretion of GnRH. For example, the low frequency GnRH pulses lead to the release of FSH and the high-frequency of GnRH pulses lead to the release of LH. Therefore, the controlled release of FSH and LH from gonadotrophs allows for precise control of gonadal function.
Bully: Brett Height: 5'8 Weight: 164 lb Victim(s): Zack Fighter: Abel Cullum Height: 5'7 Weight: 158 lb Money earned by Bully: $1000 Money earned by victim(s): $9000 Original airing: Friday October 4, 2012.
However, some studies have also shown that malolactic fermentation may diminish primary fruit aromas such as Pinot noir, often losing raspberry and strawberry notes after MLF. Additionally, red wines may endure a loss of color after MLF due to pH changes that causes a shift in the equilibrium of the anthocyanins which contribute to the stability of color in wine.
Within the last few years several SMIs with a much higher selectivity towards CK1δ than to other CK1 isoforms have been described which are also effective in animal models. Treatment of rats, mice, monkeys and zebrafishes with PF-670462 (4-[3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine) results in a phase shift in circadian rhythm. Furthermore, it blocks amphetamine-induced locomotion in rats, prevents the alcohol deprivation effect in rat, and inhibits acute and chronic bleomycin-induced pulmonary fibrosis in mice. PF-670462 also stalls deterioration caused by UVB eye irradiation in a mouse model of ulcerative colitis, and reduces the accumulation of leukemic cells in the peripheral blood and spleen in a mouse model for Chronic lymphocytic leukemia (CLL). PF-5006739, 4-[4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl]pyrimidin-2-amine derivative attenuate the opioid drug-seeking behavior in rodents. Furthermore, it leads to a phase delay of circadian rhythm in nocturnal and diurnal animal models. N-benzothiazolyl-2-phenyl acetamide derivatives developed by Salado and co-workers show protective effects on in vivo hTDP-43 neurotoxicity in Drosophila. Interestingly, inhibitors of Wnt production (IWPs), known to inhibit O-acyltransferase porcupine (Porcn) and to be antagonists of the Wnt pathway, show structural similarities to benzimidazole-based CK1 inhibitors, among them Bischof-5 and are therefore highly potent in specifically inhibiting CK1δ.
Sources: en.wikipedia.org
== Regulation == Use of the recombinant supplement has been controversial. The assessment of the FDA is that there is no significant difference between milk from treated and untreated cows. Twenty-one other countries have also approved marketing of rBST: Brazil, Chile, Colombia, Costa Rica, Ecuador, Egypt, Guatemala, Honduras, Jamaica, Lebanon, Mexico, Panama, Paraguay, Peru, Salvador, South Africa, South Korea, Uruguay, and Venezuela. However, regulatory bodies in several countries, such as Canada, Japan, Pakistan, Australia, New Zealand, and Argentina, along with the EU, rejected Monsanto's application to sell rBST because rBST increases the risk of health problems in cows, including mastitis, reduced fertility, and reduced body condition. In Canada, bulk milk products from the United States that have been produced with rBST are still allowed to be sold and used in food manufacture (cheese, yogurt, etc.) due to loopholes in the ingredient labelling system. The FDA, World Health Organization, and National Institutes of Health have independently stated that dairy products and meat from rBST-treated cows are safe for human consumption. In 1990, the EU placed a moratorium on its sale by all member nations. It was turned into a permanent ban starting from 1 January 2000; the decision was based solely on veterinary concerns, laws, and treaties. An in-depth report published in 1999 analysed in detail the various human health risks associated with rBST.
=== Rubidium–strontium dating === While Hahn was in North America in 1905–1906, his attention had been drawn to a mica-like mineral from Manitoba that contained rubidium. He had studied the radioactive decay of rubidium-87, and had estimated its half-life at 2 × 1011 years. It occurred to him that by comparing the quantity of strontium in the mineral (which had once been rubidium) with that of the remaining rubidium, he could measure the age of the mineral, assuming that his original calculation of the half-life was reasonably accurate. This would be a superior dating method to studying the decay of uranium, because some of the uranium turns into helium, which then escapes, resulting in rocks appearing to be younger than they really were. Jacob Papish helped Hahn obtain several kilograms of the mineral. In 1937, Strassmann and Ernst Walling extracted 253.4 milligrams of strontium carbonate from 1,012 grams of the mineral, all of which was the strontium-87 isotope, indicating that it had all been produced from radioactive decay of rubidium-87. The age of the mineral had been estimated at 1,975 million years from uranium minerals in the same deposit, which implied that the half-life of rubidium-87 was 2.3 × 1011 years: quite close to Hahn's original calculation. Rubidium–strontium dating became a widely used technique for dating rocks in the 1950s, when mass spectrometry became common.
==== Cancer health claims ==== The U.S. Food and Drug Administration initiated a process of reviewing and approving food and dietary supplement health claims in 1993. Reviews of petitions results in proposed claims being rejected or approved. If approved, specific wording is allowed on package labels. In 1999, a second process for claims review was created. If there is not a scientific consensus on the totality of the evidence, a Qualified Health Claim (QHC) may be established. The FDA does not "approve" qualified health claim petitions. Instead, it issues a Letter of Enforcement Discretion that includes very specific claim language and the restrictions on using that wording. The first QHCs relevant to vitamin E were issued in 2003: "Some scientific evidence suggests that consumption of antioxidant vitamins may reduce the risk of certain forms of cancer." In 2009, the claims became more specific, allowing that vitamin E might reduce the risk of renal, bladder and colorectal cancers, but with required mention that the evidence was deemed weak and the claimed benefits highly unlikely. A petition to add brain, cervical, gastric and lung cancers was rejected. A further revision, May 2012, allowed that vitamin E may reduce risk of renal, bladder and colorectal cancers, with a more concise qualifier sentence added: "FDA has concluded that there is very little scientific evidence for this claim." Any company product label making the cancer claims has to include a qualifier sentence.
Alexandra Lynn Medlin, Personal Assistant to British High Commissioner, Cape Town. Ian Adie Murray. For services to education in Murree, Pakistan. Ng Shui-Lai, . For services to welfare, Hong Kong. Edward George Pryor, , Principal Government Town Planner, Hong Kong. Olivia Margaret, Lady Roseveare. For services to education in Malawi Tatica Ernestine Scatliffe. For services to nursing and voluntary work in British Virgin Islands. Leonard Scott, lately Adviser on English Language, European Commission. Josephine Chang Siao Fong-fong. For services to the performing arts, Hong Kong. Neville Maxwell Alexander Smith, lately Chief Immigration Officer, Bermuda. Robert Soto. For services to Scuba diving, British Virgin Islands Edith Margaret Stewart, Matron, Bangkok Nursing Home, Thailand. Heather Themistocleous, Headmistress, Junior (Anglo-Cypriot) School, Nicosia. David Straiten Thomson. For welfare services to the community, Kenya. Valerie Ann Treitlein, Honorary British Consul, Conakry. Carlye Wai-Ling Tsui, . For services to the community, Hong Kong. Valentine Thomas Tudball. For services to the British community in Beirut. Michael Julian Christopher Waters, Deputy Political Adviser, Hong Kong. John Anthony Weaver. For services to the Anglican community, Sliema, Malta. The Reverend Colin Andrew Westmarland. For services to the Church of Scotland, Malta. Henry Winston Willans. For services to the British community, Uruguay. Angela Cheung Wong Wan Yiu, JP. For services to education and hospital administration, Hong Kong. Sister Annie Margaret Wong Kam-lin, Principal, St.
Spironolactone, also known as 7α-acetylthiospirolactone, is a steroidal 17α-spirolactone, or more simply a spirolactone. It can most appropriately be conceptualized as a derivative of progesterone, itself also a potent antimineralocorticoid, in which a hydroxyl group has been substituted at the C17α position (as in 17α-hydroxyprogesterone), the acetyl group at the C17β position has been cyclized with the C17α hydroxyl group to form a spiro 21-carboxylic acid γ-lactone ring, and an acetylthio group has been substituted in at the C7α position. These structural modifications of progesterone confer increased oral bioavailability and potency, potent antiandrogenic activity, and strongly reduced progestogenic activity. The C7α substitution is likely responsible for or involved in the antiandrogenic activity of spironolactone, as 7α-thioprogesterone (SC-8365), unlike progesterone, is an antiandrogen with similar affinity to the AR as that of spironolactone. In addition, the C7α substitution appears to be responsible for the loss of progestogenic activity and good oral bioavailability of spironolactone, as SC-5233, the analogue of spironolactone without a C7α substitution, has potent progestogenic activity but very poor oral bioavailability similarly to progesterone.
Sources: en.wikipedia.org
Many species have so-called sex chromosomes that determine the sex of each organism. In humans and many other animals, the Y chromosome contains the gene that triggers the development of the specifically male characteristics. In evolution, this chromosome has lost most of its content and also most of its genes, while the X chromosome is similar to the other chromosomes and contains many genes. This being said, Mary Frances Lyon discovered that there is X-chromosome inactivation during reproduction to avoid passing on twice as many genes to the offspring. Lyon's discovery led to the discovery of X-linked diseases.
== Selected-ion monitoring chromatogram (SIM) == A selected-ion monitoring (SIM) chromatogram is similar to an EIC/XIC, with the exception that the mass spectrometer is operated in SIM mode, such that only preselected m/z values are detected in the analysis. SIM experiments can be performed using mass spectrometry (MS) or tandem mass spectrometry (MS/MS) instruments. They are more common on MS instruments. This differs significantly from the extracted-ion chromatogram mentioned above in that only data for the ion(s) of interest are collected in a SIM experiment; for extracted-ion chromatograms (EIC or XIC), data for an entire mass range are collected during the run and then examined for analytes of interest after the completion of the run.
Levothyroxine, also known as L-thyroxine, is a synthetic form of the thyroid hormone thyroxine (T4). It is used to treat thyroid hormone deficiency (hypothyroidism), including a severe form known as myxedema coma. It may also be used to treat and prevent certain types of thyroid tumors. It is not indicated for weight loss. Levothyroxine is taken orally (by mouth) or given by intravenous injection. Levothyroxine has a half-life of 7.5 days when taken daily, so about six weeks is required for it to reach a steady level in the blood. Side effects from excessive doses include weight loss, trouble tolerating heat, sweating, anxiety, trouble sleeping, tremor, and fast heart rate. Use is not recommended in people who have had a recent heart attack. Use during pregnancy has been found to be safe. Dosing should be based on regular measurements of thyroid-stimulating hormone (TSH) and T4 levels in the blood. Much of the effect of levothyroxine is following its conversion to triiodothyronine (T3). Levothyroxine was first made in 1927. It is on the World Health Organization's List of Essential Medicines. Levothyroxine is available as a generic medication. In 2024, it was the second most commonly prescribed medication in the United States, with more than 80 million prescriptions.
In May 2009, Gil Kerlikowske, Director of the ONDCP – Obama's drug czar – indicated that the Obama administration did not plan to significantly alter drug enforcement policy, but that it would not use the term "war on drugs", considering it to be "counter-productive". In August 2010, Obama signed the Fair Sentencing Act into law, reducing the 100:1 sentencing disparity between crack and powder cocaine to 18:1 for pending and future cases. In 2013, Obama's Justice Department issued a policy memorandum known as the Cole Memo, stating that it would defer to state laws that authorize the production, distribution and possession of cannabis, "based on assurances that those states will impose an appropriately strict regulatory system." In 2011, the Global Commission on Drug Policy, an international non-governmental group composed primarily of former heads of state and government, and leaders from various sectors, released a report that stated, "The global war on drugs has failed." It recommended a paradigm shift, to a public health focus, with decriminalization for possession and personal use. Obama's ONDCP did not support the report, stating: "Drug addiction is a disease that can be successfully prevented and treated. Making drugs more available ... will make it harder to keep our communities healthy and safe."
J.J. Thomson (1897) "Cathode Rays", The Electrician 39, 104, also published in Proceedings of the Royal Institution 30 April 1897, 1–14 – first announcement of the "corpuscle" (before the classic mass and charge experiment) J.J. Thomson (1897), Cathode rays, Philosophical Magazine, 44, 293 – the classic measurement of the electron mass and charge J.J. Thomson (1904), "On the Structure of the Atom: an Investigation of the Stability and Periods of Oscillation of a number of Corpuscles arranged at equal intervals around the Circumference of a Circle; with Application of the Results to the Theory of Atomic Structure," Philosophical Magazine Series 6, Volume 7, Number 39, pp. 237–265. This paper presents the classical "plum pudding model" from which the Thomson Problem is posed. J. J. Thomson (1906). "On the Number of Corpuscles in an Atom" (PDF). Philosophical Magazine. 6. 11 (66): 769–781. doi:10.1080/14786440609463496. Joseph John Thomson (1908). On the Light Thrown by Recent Investigations on Electricity on the Relation Between Matter and Ether: The Adamson Lecture Delivered at the University on November 4, 1907. University Press. J.J. Thomson (1912), "Further experiments on positive rays" Philosophical Magazine, 24, 209–253 – first announcement of the two neon parabolae J.J. Thomson (1913), Rays of positive electricity, Proceedings of the Royal Society, A 89, 1–20 – discovery of neon isotopes J.J. Thomson (1923), The Electron in Chemistry: Being Five Lectures Delivered at the Franklin Institute, Philadelphia. Thomson, Sir J. J.
Sources: en.wikipedia.org
Reversed-phase HPLC gives the main purity figure, most often with UV detection near 214 nanometres. Mass spectrometry then confirms the molecular mass. Together the two methods distinguish a correct sequence from a closely related impurity.
The main chemical risks are methionine oxidation and backbone hydrolysis in solution. Moisture and repeated temperature cycling accelerate both processes. Dry powder held cold and desiccated is considerably more stable than any reconstituted preparation.
It holds a medicine registration in Russia, where it has been used clinically for decades. In most other countries it is treated as a research chemical. That split explains the uneven distribution of clinical literature.
Dry powder is normally held at -20 °C or lower, away from light and moisture. Sealed vials can also be kept at 2-8 °C for shorter intervals. Warming to room temperature before opening prevents condensation.